Primary percutaneous coronary interventions in nonagenarians

Clinical Cardiology

Volumn 33, Issue 3, 2010, Pages 157-161

  Koutouzis, Michael ^a   Grip, Lars ^a   Matejka, Göran ^a   Albertsson, Per ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EPTIFIBATIDE; HEPARIN; HIRULOG; WARFARIN;

AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; CORONARY STENT; DISEASE CLASSIFICATION; FEMALE; HEART FUNCTION; HEART INFARCTION; HUMAN; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; ST SEGMENT ELEVATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ANGIOPLASTY, BALLOON, CORONARY; FEASIBILITY STUDIES; FEMALE; HEART VENTRICLES; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; SWEDEN; TREATMENT OUTCOME;

EID: 77949709933     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20720     Document Type: Article

References (23)

1. Gillum BS, Graves EJ, Wood E. National hospital discharge survey. Vital Health Stat 13. 1998;133:i-v, 1-51.
2. White HD. Thrombolytic therapy in the elderly. Lancet. 2000; 356:2028-2030.
3. van't Hof AW, Liem A, Suryapranata H, et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Myocardial Infarction Study Group. Circulation. 1998;97: 2302-2306.
4. Burn TR, Klima M, Teasdale TA, et al. Morphometry of the aging heart. Mod Pathol. 1990;3:336-342.
5. Nixon JV, Hallmark H, Page K, Raven PR,Michell JH. Ventricular performance in human heart aged 61 to 73 years. Am J Cardiol. 1985;56:932-937.
6. Ornato JP, Pederdy MA, Tadler SC, et al. Factors associated with the occurrence of cardiac arrest during hospitalization for acute myocardial infarction in the Second National Registry of Myocardial infarction in the US. Resuscitation. 2001;48: 117-123.
7. Bueno H, Martinez-Selles M, Perez-David E, et al. Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acutemyocardial infarction. Eur Heart J. 2005;26:1705-1711.
8. Alexander KP, Newby K, Armstrong PW, et al. Acute coronary syndromes in the elderly, Part II. ST-segment elevation myocardial infarction. Circulation. 2007;115:2570-2589.
9. Briton A, Mckee M, Black N, et al. Threats to applicability of randomized trials: exclusions and selective participation. J Health Serv Res Policy. 1999;4:112-121.
10. Lee PY, Alexander KP, Hammil BG, et al. Presentation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA. 2001; 286:708-713.
11. Boucher JM, Racine J, Thanh TH, et al.; Quebec Acute Coronary Care Working Group. Age-related differences in in-hospital mortality and the use of thrombolytic therapy for acute myocardial infarction. CMAJ. 2001;164:1285-1290.
12. Berger AK, Radford MJ, Wang Y, et al. Thrombolytic therapy in older patients. J Am Coll Cardiol. 2000;36:366-374.
13. Hovanesyan A, Rich MW. Outcomes of acute myocardial infarction in nonagenarians. Am J Cardiol. 2008;101:1379-1383.
14. Stone GW, Grines CL, Browne KF, et al. Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol. 1995;25:370-377.
15. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. Aclinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997;336:1621-1628.
16. Andersen HR, Nielsen TT, Rasmunssen K, et al; DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733-742.
17. Goldenberg I, Matetzky S, Halkin A, et al. Primary angioplasty with routine stenting compared with fibrinolytic therapy in elderly patients with acute myocardial infarction. Am Heart J. 2003;145: 862-867.
18. de Boer MJ, Ottervanger JP, van't Hof AW, et al.; Zwolle Myocardial Infarction Study Group. Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol. 2002;39:1723-1728.
19. Antoniucci D, Valenti R, Santoro GM, et al. Systematic primary angioplasty in octogenarians and older patients. Am Heart J. 1999;138:670-674.
20. Valente S, Lazzeri C, Salvadori C, et al. Effectiveness and safety of routine primary angioplasty in patients aged > or= 85 years with acute myocardial infarction. Circ J. 2008;72:67-70.
21. Hovanesyan A, Rich MW. Outcomes of acute myocardial infarction in nonagenarians. Am J Cardiol. 2009;101:1379-1383.
22. Stone GW, Grines CL, Cox DA, et al.; Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximad in acute myocardial infarction. N Engl J Med. 2002;346:957-966.
23. Stone GW, Witzenbichler B, Guagliumi G, et al; HORIZONS-AMI Trial Investigators. Bivalirudin during primary PCI in acute myocardial infarction.N Engl J Med. 2008;358:2218-2230.